Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Drug Targets. Cardiovascular & Haematological Disorders
|
March 1, 2006
Preventing atherosclerosis with angiotensin-converting enzyme inhibitors: emphasis on diabetic atherosclerosis
T J Allen, K A Jandeleit-Dahm
PPAR Research
|
March 27, 2012
The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes
M C Thomas, K A Jandeleit-Dahm, C Tikellis
Diabetologia
|
February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation
A C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.
Diabetes & Metabolism
|
September 2, 2015
Linking RAGE and Nox in diabetic micro- and macrovascular complications
C Koulis, A M D Watson, S P Gray, et al.
Current Pharmaceutical Design
|
September 28, 2007
PPARs and diabetes-associated atherosclerosis
A C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Diabetologia
|
March 1, 2012
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K Huynh, H Kiriazis, X-J Du, et al.
Atherosclerosis
|
December 21, 2007
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
C Tikellis, K A Jandeleit-Dahm, K Sheehy, et al.
Diabetologia
|
October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis
Y Pham, Y Tu, T Wu, et al.
Diabetologia
|
December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice
E Di Marco, S P Gray, P Chew, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Drug Targets. Cardiovascular & Haematological Disorders
|
March 1, 2006
Preventing atherosclerosis with angiotensin-converting enzyme inhibitors: emphasis on diabetic atherosclerosis
T J Allen, K A Jandeleit-Dahm
PPAR Research
|
March 27, 2012
The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes
M C Thomas, K A Jandeleit-Dahm, C Tikellis
Diabetologia
|
February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation
A C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.
Diabetes & Metabolism
|
September 2, 2015
Linking RAGE and Nox in diabetic micro- and macrovascular complications
C Koulis, A M D Watson, S P Gray, et al.
Current Pharmaceutical Design
|
September 28, 2007
PPARs and diabetes-associated atherosclerosis
A C Calkin, K A Jandeleit-Dahm, E Sebekova, et al.
Diabetologia
|
July 3, 2008
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
A C Calkin, S Giunti, K J Sheehy, et al.
Diabetologia
|
March 1, 2012
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K Huynh, H Kiriazis, X-J Du, et al.
Atherosclerosis
|
December 21, 2007
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
C Tikellis, K A Jandeleit-Dahm, K Sheehy, et al.
Diabetologia
|
October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis
Y Pham, Y Tu, T Wu, et al.
Diabetologia
|
December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) mice
E Di Marco, S P Gray, P Chew, et al.
Page
of 1